top of page
At Anavex Life Sciences, we are dedicated to improving overall quality of life for people living with neurodegenerative and neurodevelopmental disorders. Our product portfolio platform is currently dedicated to solving the following list of life-altering conditions.
Alzheimer's disease (AD)
ANAVEX®2-73 (blarcamesine) has been featured as a Disease-Modifying Small Molecule in Phase 3 Clinical Trials in a New Publication in Medical Journal titled “Future Avenues for Alzheimer’s Disease Detection and Therapy.”
bottom of page